A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
מצבים רפואיים
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Anhui Provincial Hospital, Hefei, Anhui, China
Contact: Study coordinator (Changcheng Zheng)Beijing Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Hui Liu)Institute of Hematology, the First Hospital of Harbin, Haerbin, Heilongjiang, China
Contact: Study coordinator (Tiejun Gong)Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
Contact: Study coordinator (Zhuogang Liu)Qilu Hospital of Shandong University, Jinan, Shangdong, China
Contact: Study coordinator (Chunyan Ji)Contact: Principal Investigator (Chunyan Ji)Contact: Principal Investigator (Jingjing Ye)Shanghai Tongji Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Ping Li)West China Hospital，Sichuan University, Chengdu, Sichuan, China
Contact: Study coordinator (Yu Wu)Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality, China
Contact: Principal Investigator (Junyuan Qi)Contact: Principal Investigator (Jianxiang Wang)
מובילי המחקר
Junyuan Qi, PHD
Principal Investigator
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Jianxiang Wang, MS
Principal Investigator
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences